Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001
Published online before print March 30, 2001, doi: 10.1161/hh0701.088840
A more recent version of this article appeared on April 13, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
88/7/688    most recent
hh0701.088840v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laugwitz, K.-L.
Right arrow Articles by Ungerer, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Laugwitz, K.-L.
Right arrow Articles by Ungerer, M.
Related Collections
Right arrow Congestive
Right arrow Gene therapy
Right arrow Receptor pharmacology
(Circulation Research. 2001;0:hh0701.088840.)
© 2001 American Heart Association, Inc.


Online First Article

Gene Transfer of Heterologous G Protein–Coupled Receptors to Cardiomyocytes

Differential Effects on Contractility

Karl-Ludwig Laugwitz1, Hans-Jörg Weig1, Alessandra Moretti, Eva Hoffmann, Peter Ueblacker, Ingo Pragst, Kai Rosport, Albert Schömig Martin Ungerer

From the Medizinische Klinik and Deutsches Herzzentrum München (K.-L.L., H.-J.W., A.M., E.H., P.U., A.S.) and Institut für Experimentelle Onkologie und Therapieforschung (I.P.), Technische Universität, Munich, and ProCorde (K.R., M.U.), Martinsried, Germany.

Correspondence to Dr Martin Ungerer, ProCorde, Fraunhoferstrasse 9, D-82152 Martinsried, Germany. E-mail: ungerer{at}procorde.com

Abstract

Abstract—In heart failure, reduced cardiac contractility is accompanied by blunted cAMP responses to ß-adrenergic stimulation. Parathyroid hormone (PTH)–related peptide and arginine vasopressin are released from the myocardium in response to increased wall stress but do not stimulate contractility or adenylyl cyclase at physiological concentrations. To bypass the defective ß-adrenergic signaling cascade, recombinant P1 PTH/PTH-related peptide receptors (rPTH1-Rs) and V2 vasopressin receptors (rV2-Rs), which are normally not expressed in the myocardium and which are both strongly coupled to adenylyl cyclase, and recombinant ß2-adrenergic receptors (rß2-ARs) were overexpressed in cardiomyocytes by viral gene transfer. The capacity of endogenous hormones to increase contractility via the heterologous, recombinant receptors was compared. Whereas V2-Rs are uniquely coupled to Gs, PTH1-Rs and ß2-ARs are also coupled to other G proteins. Gene transfer of rPTH1-Rs or rß2-ARs to adult cardiomyocytes resulted in maximally increased basal contractility, which could not be further stimulated by adding receptor agonists. Agonists at rPTH1-Rs induced increased cAMP formation and phospholipase C activity. In contrast, healthy or failing rV2-R–expressing cardiomyocytes showed unaltered basal contractility. Their contractility and cAMP formation increased only at agonist exposure, which did not activate phospholipase C. In summary, we found that gene transfer of PTH1-Rs to cardiomyocytes results in constitutive activity of the transgene, as does that of ß2-ARs. In the absence of receptor agonists, rPTH1-Rs and rß2-ARs increase basal contractility, coupling to 2 G proteins simultaneously. In contrast, rV2-Rs are uniquely coupled to Gs and are not constitutively active, retaining their property to be activated exclusively on agonist stimulation. Therefore, gene transfer of V2-Rs might be more suited to test the effects of cAMP-stimulating receptors in heart failure than that of PTH1-Rs or ß2-ARs.


Key Words: gene transfer • receptor • heart failure




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. B. Sneddon and P. A. Friedman
{beta}-Arrestin-Dependent Parathyroid Hormone-Stimulated Extracellular Signal-Regulated Kinase Activation and Parathyroid Hormone Type 1 Receptor Internalization
Endocrinology, August 1, 2007; 148(8): 4073 - 4079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Munch, K. Rosport, C. Baumgartner, Z. Li, S. Wagner, A. Bultmann, and M. Ungerer
Functional alterations after cardiac sodium-calcium exchanger overexpression in heart failure
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H488 - H495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Jansen, P. Gres, C. Umschlag, F. R. Heinzel, H. Degenhardt, K.-D. Schluter, G. Heusch, and R. Schulz
Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H49 - H55.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Vatner
Stimulating G Protein-Coupled Receptors : Cure or Cause for Heart Failure?
Circ. Res., April 13, 2001; 88(7): 645 - 647.
[Full Text] [PDF]